Erysipelas medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
The mainstay of therapy for Erysipelas involves antimicrobial therapy with either [[Penicillins]], [[Erythromycin]], [[Ceftriaxone]], or [[Cefazolin]]. | |||
==Treatment== | ==Treatment== | ||
Revision as of 19:18, 12 August 2015
|
Erysipelas Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erysipelas medical therapy On the Web |
|
American Roentgen Ray Society Images of Erysipelas medical therapy |
|
Risk calculators and risk factors for Erysipelas medical therapy |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The mainstay of therapy for Erysipelas involves antimicrobial therapy with either Penicillins, Erythromycin, Ceftriaxone, or Cefazolin.
Treatment
Antimicrobial Regimen
- Erysipelas[1]
- 1. Adults
- Preferred regimen (1): Penicillin 500 mg PO qid
- Preferred regimen (2): Amoxicillin 500 mg PO qid
- Preferred regimen (3): Erythromycin 250 mg PO qid
- Preferred regimen (4): Ceftriaxone 1 g IV q24h
- Preferred regimen (5): Cefazolin 1 to 2 g IV q8h
- 2. Pediatrics
- Preferred regimen (1): Penicillin 25 to 50 mg/kg/day PO tid or qid
- Preferred regimen (2): Amoxicillin 25 to 50 mg/kg/day PO tid
- Preferred regimen (3): Erythromycin 30 to 50 mg/kg/day PO bid to qid
- Preferred regimen (4): Ceftriaxone 50 to 75 mg/kg/day IV q12-24h
- Preferred regimen (5): Cefazolin 100 mg/kg/day IV q8h
References
- ↑ Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.